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News & Analysis

“The suspicions are born of a forgone
era,” said Rose, director of the Duke University Center for Smoking Cessation, who has
received funding over the years from PMI
and Philip Morris USA. “The real enemy is
death and disease caused by smoking,” not
the tobacco industry.
Today, Rose said, his center is funded
exclusively by National Institutes of Health
grants. Still, he said, “I would not hesitate to apply for funding from the foundation. The merits of accepting funding to
do public health [research] outweigh
the risks.”
However, recent reports suggest that
long-held suspicions may still be wellfounded. Shortly before the foundation was
formally launched, Reuters News Agency
published an investigation, based on internal PMI documents, that concluded the
company has been trying to weaken
Framework Convention on Tobacco Control provisions curbing tobacco use. Ironically, Yach helped develop the tobacco

control convention, which coordinates
global efforts to combat tobacco use.

Informed Decision
In a recent JAMA Viewpoint, published a few
months before the formal launch of Yach’s
foundation, Sandro Galea, MD, DrPH, dean
of the Boston University School of Public
Health, and his coauthor wrote: “Schools
of public health should not accept money if
doing so pushes them to be something that
is not consistent with their mission to promote the health of the public.”
However, Galea says he needs more information about the smoke-free foundation
before deciding whether to sign a statement
that his school will not accept its money. “I
think all money comes with conflicts,” he said.
“Should we take money from large conglomerateswherepartoftheirmanufacturinggoes
to building parts of weapons?” To help inform him and his faculty and students, Galea
said, he has invited Yach and Daube to speak
at a symposium on campus in the fall.

As of mid-June, the foundation had not
yet announced the recipients of its first
round of grants. “My guess is that they’re going to fund some of the zealous supporters
of e-cigarettes and people who haven’t really
worked intensely on tobacco,” said Matthew
Myers, president of the Washington, DC–
based Campaign for Tobacco-Free Kids,
which works in about 25 countries around
the world.
While PMI may be developing smokefree alternatives, Myers said, he has never
seen the company market combustible cigarettes as aggressively as it is now.
“One of my strongest criticisms of the
foundation is they did not demand, as a condition of accepting the money, a real change
in Philip Morris’s business practices,” Myers
said. “In the absence of Philip Morris agreeing to do that, it is obvious that this grant is a
diversion to make it appear that they are part
of the solution, not the problem itself.”
Note: Source references are available through
embedded hyperlinks in the article text online.
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O

n May 8, the Democratic Republic of Congo (DRC) notified the
Wo r l d H e a l t h O r g a n i z a t i o n
(WHO) of a confirmed outbreak of Ebola
in Bikoro, on the shores of Lake Tumba in
Équateur Province. Ebola in the DRC is not
unexpected. The first-ever identified
Ebola outbreak occurred in the DRC—then
Zaire—in 1976. This is the ninth of DRC’s
outbreaks, which until now have been
confined mainly to rural areas. With high
fatality rates, earlier outbreaks quickly
burned out due to the natural firewall
of remoteness.
Bikoro and a nearby village, IkokoImpenge, are rural, but on May 16, the WHO
confirmed spread to Mbandaka, home to
1.2 million people. Peter Salama, MD, MPH,
head of the WHO’s Emergencies Program,
called urban spread a game changer that
could spill over porous borders. Lake
Tumba flows to the Congo River, connecting 2 capital cities (Kinshasa, DRC, and
Brazzaville, Republic of the Congo) along
the waterway. The WHO warned that 9

neighboring countries, including the Central African Republic, are at high risk.
The DRC outbreak is the WHO’s first
major test since the West African Ebola
epidemic (2013-2016), which infected
28 600 and killed 11 325. Four global
commissions sharply critiqued the WHO’s
response. The agency took 4 to 5 months
after international spread before declaring
a Public Health Emergency of International
Concern (PHEIC) under the International
Health Regulations (IHR). The WHO’s staffing and budget cuts had so badly weakened its capacity for a rapid response and
exhibited such poor coordination of local
and international actors that the epidemic
spun out of control.
This time the WHO’s response has
been swift and comprehensive. It operationalized the Emergencies Program and
Contingency Fund for Emergencies, 2 crucial WHO reforms in the wake of the 20132016 epidemic. The WHO deployed an
experimental vaccine called rVSV-ZEBOV,
marking a paradigm shift. Director-General
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Te d r o s A d h a n o m G h e b r eye s u s a n d
Dr Salama flew to Bikoro, partnering with
DRC’s Ministry of Health, a powerful symbol of political commitment.

Lessons Learned by the WHO
WHO transformed its work on pandemic
preparedness and response, learning
major lessons:
Declaring a PHEIC Under the IHR. On
May 18, only 2 days after urban spread, the
director-general convened an emergency
committee under the IHR. The committee
decided not to declare a PHEIC but urged
the WHO to be on high alert, promising
to reconvene if the virus spread internationally. The committee urged against
travel or trade restrictions, which had devastated West Africa during the 2013-2016
Ebola epidemic. The region faces key challenges: cases in a congested city; multiple
outbreaks in remote, hard-to-reach locations; health professionals infected, posing
a risk for amplification; and logistical challenges of poor infrastructure (for example,
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unpaved roads, lack of electricity, and
limited telecommunications). The outbreak’s epicenter is remote and impoverished. These factors pose challenges for
surveillance, case detection and confirmation, contact tracing, and access to vaccines
and therapeutics.
Emergency Response. Traditionally, the
WHO has been primarily a normative and
technical organization, with weak operational capacity to respond to health emergencies. The organization quickly activated
its Incident Management System, created in
the wake of the West African epidemic, to
place responders, equipment, and supplies
on the ground, while coordinating local, national, and international actors. The WHO’s
Global Outbreak Alert and Response Network and Emergency Medical Teams initiative will offer additional coordination and
technical support. The organization released
$2.6 million from the new contingency fund
for health emergencies to provide vitally
needed resources. It has empowered the
DRC’s Ministry of Health, while partnering
with international organizations (Gavi, the
Vaccine Alliance; United Nations Children’s
Fund (UNICEF); the International Federation of Red Cross and Red Crescent Societies [IFRC]), and civil society (Médecins
Sans Frontières). International partners have
improved logistics so health workers, medical equipment, and vaccines can move to
areas of critical need.
Vaccine. The WHO, with partners, has
sent rVSV-ZEBOV vaccine to the DRC.
Merck provided it without charge, while
Gavi donated $1 million for health workers
and logistics. The rVSV-ZEBOV vaccine is
not officially licensed, but the DRC authorized its compassionate use pending regulatory approval. It proved highly effective
in trials in Guinea and Sierra Leone toward
the end of the West African epidemic. Subsequent trials in Africa, Europe, and the
United States reinforced the vaccine’s
effectiveness. Marking a turning point, vaccination transforms the response from a
strategy of containment to one of prevention and protection. The vaccination campaign targets frontline responders, health
workers, and contacts of infected persons.
Using a “ring” strategy, vaccination creates
a buffer of immune individuals to prevent
virus transmission.
The WHO and the DRC also must
decide whether to approve and deploy

126

experimental medicines. During the West
African epidemic, aid workers often got preferential access to investigational drugs such
as ZMapp. Giving priority to foreign responders generated distrust. Another vital lesson
was to give the host country greater ownership of medical countermeasures.
2014-2016 Total Funding for Ebola Virus
Disease Outbreak Responsea

US government
United Kingdom
Germany
World Bank
European Commission
France
Sweden
Japan
Canada
Netherlands
Total

Humanitarian Funding,
2014-2016, US $
2 396 694 509
363 798 934
166 555 655
139 598 831
118 947 563
108 358 081
87 372 415
78 941 052
78 020 740
72 866 893
3 611 154 673

a Funding figures as of January 21, 2016. All international

figures are according to the United Nations Office for the
Coordination of Humanitarian Affairs (OCHA) Financial
Tracking Service and are based on international
commitments during 2014, 2015, and to date in 2016.
According to the US government, its figures reflect its
commitments from fiscal years 2014, 2015, and 2016,
which began October 1, 2014, and October 1, 2015,
respectively.
Source: US Agency for International Development
(USAID) West Africa—ebola outbreak fact sheet, No. 6;
September 17, 2014. https://www.usaid.gov/ebola
/fy14/fs06. Accessed June 12, 2018.

Although vaccination could be transformational, the campaign faces enormous
challenges, including surveillance, laboratory confirmation, and locating contacts.
Affected populations are difficult to reach
and include diverse ethnic communities
speaking a dozen languages. Vaccine distribution requires cold storage (−70°C to
−80°C), which requires reliable roads, electricity, and generators. Fostering public
trust is essential, requiring deep understanding of local cultures and genuine
listening to community concerns.

Challenges to Emergency
Preparedness
The WHO’s Strategic Response Plan estimates that $26 million is required for DRC
Ebola funding, a target already reached.
The World Bank will distribute money for
the first time from its Pandemic Emergency
Financing Facility. The resources required
to quell this outbreak through proactive
measures pale in comparison to the well more
than $3 billion the West African epidemic

cost the global community (see table).
Although the health emergencies program
and contingency fund are innovative
reforms, both are significantly underfunded. The United States was the top
donor during the West African epidemic,
yet the Trump administration is now seeking
to vastly scale back pandemic preparedness. Member states need to act as stakeholders in the WHO’s success to ensure
preparedness, but thus far the organization
has been chronically underfunded.
Beyond global governance, robust
national health systems are the foundation
of global health security. The IHR requires all
states to maintain core health system capacities, but most have not complied. Investing in health systems is lagging, both
from domestic governments and international donors. The Joint External Evaluation to objectively assess health system capacities was another post-Ebola reform, and
has assessed 67 countries. Yet significant
gaps persist, affecting countries’ surveillance and response.
Countries also frequently fail to comply
with IHR recommendations to avoid unnecessary quarantines and trade and travel
restrictions, with many disregarding WHO
recommendations during the West African
epidemic. Fearing reductions in travel, tourism, and trade, governments may not rapidly report disease outbreaks.
The World Health Assembly recently
underscored the urgency of containing the
DRC outbreak. Beyond expressions of concern, countries must commit to a global
push to implement IHR core capacities,
strengthen health systems, and empower
the WHO.
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